Skip to main content
Presentation
Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients With Ankylosing Spondylitis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry. Annual Meeting the Academy of Managed Care Pharmacy (AMCP), Boston, Apr 2018.
Annual Meeting the Academy of Managed Care Pharmacy (AMCP) (2018)
  • Philip Mease, Providence St. Joseph Health
  • Désirée van der Heijde, Leiden University
  • C Karki
Disciplines
Publication Date
April, 2018
Location
Boston
Citation Information
Philip Mease, Désirée van der Heijde and C Karki. "Discontinuation of Tumor Necrosis Factor Inhibitor Therapy in US Patients With Ankylosing Spondylitis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry. Annual Meeting the Academy of Managed Care Pharmacy (AMCP), Boston, Apr 2018." Annual Meeting the Academy of Managed Care Pharmacy (AMCP) (2018)
Available at: http://works.bepress.com/philip-mease/134/